tetano
Editor, Senior Moderator
Curr Microbiol
. 2024 Sep 3;81(10):338.
doi: 10.1007/s00284-024-03854-y. A Cluster of Diutina catenulata Funguria in Patients with Coronavirus Disease 2019 (COVID-19) Hospitalized in a Tertiary Reference Hospital from Rio de Janeiro, Brazil
Rodrigo Almeida-Paes[SUP] #[/SUP][SUP] 1 [/SUP], Marcus de Melo Teixeira[SUP] #[/SUP][SUP] 2 3 [/SUP], Fernanda Alves de Oliveira[SUP] 1 [/SUP], Marcos de Abreu Almeida[SUP] 1 4 [/SUP], Fernando Almeida-Silva[SUP] 1 [/SUP], Kim Mattos Geraldo[SUP] 5 [/SUP], Estevão Portela Nunes[SUP] 5 [/SUP], Bridget M Baker[SUP] 2 [/SUP], Jason E Stajich[SUP] 6 [/SUP], Beatriz Grinsztejn[SUP] 5 [/SUP], Valdilea Gonçalves Veloso[SUP] 5 [/SUP], Andrea d'Avila Freitas[SUP] 1 [/SUP], Rosely Maria Zancopé-Oliveira[SUP] 7 [/SUP]
Affiliations
During the COVID-19 pandemic, fungal infections, especially pulmonary aspergillosis, mucormycosis, and invasive candidiasis, have emerged as a significant health concern. Beyond Candida albicans, the most common cause of invasive candidiasis, other rare ascomycetous yeast species have been described in tertiary care units, potentially posing a broader health threat. We have isolated, from September 2020 to June 2021, nine Diutina catenulata strains from urine samples of six patients. This was intriguing as this fungus had not been previously identified in our institution, nor after June 2021. Therefore, we decided to outline the clinical features of the patients with this rare pathogen, to describe phenotypic characteristics, including antifungal susceptibility profiles, of this yeast species and to identify the genetic makeup through whole-genome sequencing analysis to evaluate if this was a cluster of genetically similar D. catenulata isolates in our institution. The strains were identified through MALDI-TOF MS analyses and Sanger sequencing of two rDNA regions. All patients yielding D. catenulata from urine samples needed ventilator support and used urinary catheters during hospitalization for treatment of COVID-19. None of them had received COVID-19 vaccines. Morphological and biochemical profiles of the nine strains were largely consistent, although fluconazole susceptibility varied, ranging from 4 to 32 μg/mL. Phylogenomic analysis revealed minimal genetic variation among the isolates, with low intrapopulation variation, supported by the identification of only 84 SNPs across all strains. Therefore, we propose that the yeast strains isolated were part of a cluster of D. catenulata funguria in the context of COVID-19.
. 2024 Sep 3;81(10):338.
doi: 10.1007/s00284-024-03854-y. A Cluster of Diutina catenulata Funguria in Patients with Coronavirus Disease 2019 (COVID-19) Hospitalized in a Tertiary Reference Hospital from Rio de Janeiro, Brazil
Rodrigo Almeida-Paes[SUP] #[/SUP][SUP] 1 [/SUP], Marcus de Melo Teixeira[SUP] #[/SUP][SUP] 2 3 [/SUP], Fernanda Alves de Oliveira[SUP] 1 [/SUP], Marcos de Abreu Almeida[SUP] 1 4 [/SUP], Fernando Almeida-Silva[SUP] 1 [/SUP], Kim Mattos Geraldo[SUP] 5 [/SUP], Estevão Portela Nunes[SUP] 5 [/SUP], Bridget M Baker[SUP] 2 [/SUP], Jason E Stajich[SUP] 6 [/SUP], Beatriz Grinsztejn[SUP] 5 [/SUP], Valdilea Gonçalves Veloso[SUP] 5 [/SUP], Andrea d'Avila Freitas[SUP] 1 [/SUP], Rosely Maria Zancopé-Oliveira[SUP] 7 [/SUP]
Affiliations
- PMID: 39223407
- DOI: 10.1007/s00284-024-03854-y
During the COVID-19 pandemic, fungal infections, especially pulmonary aspergillosis, mucormycosis, and invasive candidiasis, have emerged as a significant health concern. Beyond Candida albicans, the most common cause of invasive candidiasis, other rare ascomycetous yeast species have been described in tertiary care units, potentially posing a broader health threat. We have isolated, from September 2020 to June 2021, nine Diutina catenulata strains from urine samples of six patients. This was intriguing as this fungus had not been previously identified in our institution, nor after June 2021. Therefore, we decided to outline the clinical features of the patients with this rare pathogen, to describe phenotypic characteristics, including antifungal susceptibility profiles, of this yeast species and to identify the genetic makeup through whole-genome sequencing analysis to evaluate if this was a cluster of genetically similar D. catenulata isolates in our institution. The strains were identified through MALDI-TOF MS analyses and Sanger sequencing of two rDNA regions. All patients yielding D. catenulata from urine samples needed ventilator support and used urinary catheters during hospitalization for treatment of COVID-19. None of them had received COVID-19 vaccines. Morphological and biochemical profiles of the nine strains were largely consistent, although fluconazole susceptibility varied, ranging from 4 to 32 μg/mL. Phylogenomic analysis revealed minimal genetic variation among the isolates, with low intrapopulation variation, supported by the identification of only 84 SNPs across all strains. Therefore, we propose that the yeast strains isolated were part of a cluster of D. catenulata funguria in the context of COVID-19.